Back to search

Article

A Harmless Avian Vaccine Virus Could Be Developed into an Off-the-Shelf “Antibiotic” for Viruses

2024-11-14

Abstract excerpt

A repurposed apathogenic double stranded (ds) RNA vaccine virus, the infectious bursal disease virus (IBDV), significantly upregulates the expressions of type I interferon (IFN) genes. IBDV superinfection therapy (SIT) has been proven to be safe and effective against hepatitis A, B, and C viruses (HAV, HBV, HCV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and herpes zoster virus (HZV). IBDV migh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9f8920ba-5d8f-5876-b266-08271fc9c53e
DOI
10.32388/az4jzv.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Harmless Avian Vaccine Virus Could Be Developed into an Off-the-Shelf “Antibiotic” for VirusesDOI 10.32388/az4jzv.2
Sting Pathway Activation by Orally Administered Attenuated dsRNA Vaccine Virus for Therapy of Viral DiseasesSemantic proximity
The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 diseaseSemantic proximity
Repurposing of Doramectin as a New Anti-Zika Virus AgentSemantic proximity
Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity
New Kids on the Block: RNA-Based Influenza Virus VaccinesSemantic proximity
Infectious bursal disease virus’ interferences with host immune cells: what do we know?Semantic proximity
Development of a recombinant VP2 vaccine for the prevention of novel variant strains of infectious bursal disease virusSemantic proximity
Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease VirusSemantic proximity
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionSemantic proximity
Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal MutagenesisSemantic proximity
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionSemantic proximity
Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsSemantic proximity
Select a neighboring publication to make it the new centre.